Congrats to Zac Taylor and Larry Belkoff in collaboration with Blue Earth Diagnostics on receiving a grant from the Sharpe-Strumia Foundation Main Line Health to support their work evaluating the use of 18F-rhPSMA-7.3 to identify metastatic disease in newly diagnosed high-risk prostate cancer!